Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Statistics

Total Valuation

STO:HNSA has a market cap or net worth of SEK 3.26 billion. The enterprise value is 3.50 billion.

Market Cap	3.26B
Enterprise Value	3.50B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

STO:HNSA has 101.76 million shares outstanding. The number of shares has increased by 29.23% in one year.

Current Share Class	101.76M
Shares Outstanding	101.76M
Shares Change (YoY)	+29.23%
Shares Change (QoQ)	+20.06%
Owned by Insiders (%)	6.21%
Owned by Institutions (%)	20.52%
Float	72.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.69
PB Ratio	-38.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.61
EV / Sales	15.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.94

Current Ratio	1.94
Quick Ratio	1.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-33.08%
Return on Invested Capital (ROIC)	-48.62%
Return on Capital Employed (ROCE)	-68.87%
Weighted Average Cost of Capital (WACC)	13.38%
Revenue Per Employee	1.78M
Profits Per Employee	-4.23M
Employee Count	125
Asset Turnover	0.23
Inventory Turnover	19.12

Taxes

In the past 12 months, STO:HNSA has paid 2.27 million in taxes.

Income Tax	2.27M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.54% in the last 52 weeks. The beta is 1.84, so STO:HNSA's price volatility has been higher than the market average.

Beta (5Y)	1.84
52-Week Price Change	+22.54%
50-Day Moving Average	34.38
200-Day Moving Average	30.99
Relative Strength Index (RSI)	40.60
Average Volume (20 Days)	458,354

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:HNSA had revenue of SEK 222.27 million and -529.25 million in losses. Loss per share was -6.52.

Revenue	222.27M
Gross Profit	138.71M
Operating Income	-520.71M
Pretax Income	-526.98M
Net Income	-529.25M
EBITDA	-518.16M
EBIT	-520.71M
Loss Per Share	-6.52

Balance Sheet

The company has 701.08 million in cash and 933.82 million in debt, with a net cash position of -232.73 million or -2.29 per share.

Cash & Cash Equivalents	701.08M
Total Debt	933.82M
Net Cash	-232.73M
Net Cash Per Share	-2.29
Equity (Book Value)	-84.13M
Book Value Per Share	-0.83
Working Capital	385.95M

Cash Flow

Operating Cash Flow	-549.17M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 62.41%, with operating and profit margins of -234.27% and -238.12%.

Gross Margin	62.41%
Operating Margin	-234.27%
Pretax Margin	-237.10%
Profit Margin	-238.12%
EBITDA Margin	-233.13%
EBIT Margin	-234.27%
FCF Margin	n/a

Dividends & Yields

STO:HNSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.23%
Shareholder Yield	-29.23%
Earnings Yield	-16.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3